Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Applications are invited for the 2014 George Herbert Hunt Travelling Scholarship to support travel abroad for clinical study or research.

The scholarship is of the value of about £3,000 and may be held with another award.  This scholarship is offered in every second year.

Candidates should either have been admitted to the Degree of Bachelor of Medicine of the University of Oxford or have passed the First Examination for the Degree of Bachelor of Medicine of the University and hold a medical degree of another British university qualifying him or her to practise medicine.  Current medical students are not eligible to apply; an award can only be made to a medical graduate who fulfils the above criteria.

Candidates are required to submit with their applications a statement of their academic record together with testimonials, and an undertaking that, if elected, they will travel abroad for a period of at least one month for the purpose of clinical study or research in medicine. 

In making the award, preference will be given to candidates who intend to engage in the practice of their profession either as surgeons or as general practitioners.

The scholar will be required to complete his or her period of travel within twelve months from the date of election, and within a reasonable period thereafter to submit to the Secretary of the Medical School for the approval of the electors a detailed report of his or her tenure of the scholarship.  Payment of nine-tenths of the scholarship will be made shortly before the period of travel, and the remaining one-tenth following the approval of the report.  The election will be made on 9 April 2014.

Applications should be sent to Mrs Laura Morgan, Medical School Office, Academic Centre, Level 2, John Radcliffe Hospital, Headington, Oxford, OX3 9DU by 21 February 2014.

Similar stories

Major grant to strengthen research and benefit patients

Oxford University Hospitals (OUH) has made a grant of £11.5 million to the University of Oxford, which the University will match with other funding, to allow the development of major clinical research facilities which have the potential to support the introduction of innovative and ground-breaking treatments for patients.

Dr Lennard Lee awarded ACP McElwain Prize for contributions to medical oncology

Dr Lee (Department of Oncology) received the award to acknowledge his contributions during the COVID-19 pandemic, through the establishment of the UK Coronavirus Cancer Monitoring Project.

Oxford joins forces with 11 universities to launch social impact investment fund

The University of Oxford has joined forces with 11 leading universities to create Impact 12, an impact investment fund to support mission-led university ventures.

Ivermectin to be investigated as a possible treatment for COVID-19 in the PRINCIPLE trial

From today, ivermectin is being investigated in the UK as part of the Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE), the world’s largest clinical trial of possible COVID-19 treatments for recovery at home and in other non-hospital settings.

Potential for radiotherapy and VTP multimodality therapy for prostate cancer

A recent collaborative study from the University of Oxford has investigated the potential benefit of a combined therapy approach to prostate cancer treatment, using radiotherapy and vascular targeted photodynamic therapy (VTP), which could lead to first-in-man early phase clinical trials.

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.